Challenge of chimpanzees immunized with a recombinant canarypox-HIV-1 virus

Virology
M GirardP N Fultz

Abstract

To evaluate the potential protective efficacy of a live recombinant human immunodeficiency virus type 1 (HIV-1) canarypox vaccine candidate, two chimpanzees were immunized five times with ALVAC-HIV-1 vCP250, a recombinant canarypox virus that expresses the HIV-1[IIIB(LAI)] gp120/TM, gag, and protease gene products. One month after the last booster inoculation, the animals were challenged by intravenous injection of cell-associated virus in the form of peripheral blood mononuclear cells from an HIV-1[IIIB(LAI)]-infected chimpanzee. One chimpanzee with a neutralizing antibody titer to HIV-1[IIIB(LAI)] of 128 at the time of challenge was protected, whereas both the second animal, with a neutralizing antibody titer of 32, and a naive control animal became infected. At 5 months after challenge, the protected chimpanzee and a third animal, previously immunized with various HIV-1[MN] antigens, were given a booster inoculation. The two animals were challenged intravenously 5 weeks later with twenty 50% tissue culture infectious doses of cell-free HIV-1[DH12], a heterologous subtype B isolate. Neither chimpanzee had neutralizing antibodies to HIV-1[DH12], and neither one was protected from infection with this isolate. The immune respons...Continue Reading

References

Jan 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M GirardE Muchmore
Mar 1, 1991·AIDS Research and Human Retroviruses·P PutkonenG Biberfeld
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·E S DaarD D Ho
Apr 1, 1989·Journal of Medical Virology·K Hedman, S A Rousseau
Jun 1, 1994·AIDS Research and Human Retroviruses·C V Hanson
Jun 1, 1996·The Journal of Infectious Diseases·K K Van RompayM L Marthas
Jun 1, 1996·Journal of Virology·M S WyandR C Desrosiers
Dec 1, 1995·AIDS Research and Human Retroviruses·S Zolla-Pazner, S Sharpe

❮ Previous
Next ❯

Citations

Oct 9, 1998·AIDS Research and Human Retroviruses·F Y TungR C Montelaro
Jul 1, 2006·Current Opinion in HIV and AIDS·Jonathan L Heeney
Sep 9, 2010·Expert Review of Vaccines·Monica VaccariGenoveffa Franchini
Apr 9, 2015·Viruses·Lucas Sánchez-SampedroMariano Esteban
Sep 25, 2002·Clinics in Laboratory Medicine·James P McGettiganMatthias J Schnell
Aug 22, 2012·Human Vaccines & Immunotherapeutics·Carmen Elena GómezMariano Esteban
Feb 11, 2014·Current Protocols in Immunology·Yongjun SuiJay A Berzofsky
Jul 2, 2003·Nature Medicine·Andrew J McMichael, Tomas Hanke
Oct 2, 2008·Alternatives to Laboratory Animals : ATLA·Jarrod Bailey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.